AbbVie (ABBV) Dividends Paid - Common (2013 - 2026)

AbbVie has disclosed Dividends Paid - Common across 14 years of filings, most recently posting $3.1 billion for Q1 2026.

• In Q1 2026, Dividends Paid - Common rose 5.5% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $11.8 billion (up 5.73% YoY), while the FY2025 annual figure was $11.7 billion, up 5.73% from the prior year.
• Dividends Paid - Common rose to $3.1 billion in Q1 2026, from $2.9 billion in the prior quarter.
• Over the last five years, Dividends Paid - Common for ABBV reached as high as $3.1 billion in Q1 2026 and fell as low as $2.5 billion in Q3 2022.
• The 5-year median for Dividends Paid - Common is $2.8 billion (2024), against an average of $2.7 billion.
• Annual changes were most pronounced in 2022 — Dividends Paid - Common gained 8.79% — and 2024, when it rose 4.17%.
• A 5-year view of Dividends Paid - Common shows it stood at $2.5 billion in 2022, then increased by 4.79% to $2.6 billion in 2023, then rose by 4.8% to $2.8 billion in 2024, then grew by 5.78% to $2.9 billion in 2025, then rose by 6.01% to $3.1 billion in 2026.
• According to Business Quant data, Dividends Paid - Common over the past three periods registered $3.1 billion, $2.9 billion, and $2.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.